data_2pea_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2pea _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ptt? . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 109.542 -0.54 . . . . 17.170000000000002 109.542 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.417 HE22 ' HB2' ' A' ' 16' ' ' GLU . 67.1 mm-40 -95.82 142.34 28.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.434 0.635 . . . . 21.890000000000001 110.264 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.1 pt -131.49 165.4 31.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 114.905 -1.043 . . . . 10.83 108.29 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -124.37 139.94 53.43 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.703 0.287 . . . . 10.609999999999999 111.277 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.2 t -122.88 123.72 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 108.594 -0.891 . . . . 9.1300000000000008 108.594 177.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.9 mttp -100.03 142.31 31.68 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.864 0.364 . . . . 20.550000000000001 110.507 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.4 p -101.83 166.07 10.86 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-O 122.099 0.952 . . . . 11.779999999999999 111.047 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 1.622 HD11 ' CB ' ' B' ' 44' ' ' ILE . 86.3 mt -64.03 -19.58 65.3 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.61 -1.632 . . . . 19.309999999999999 111.189 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 1.657 ' HA ' ' CE1' ' B' ' 68' ' ' HIS . 43.8 p -93.34 0.01 56.77 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.189 0.44 . . . . 23.140000000000001 112.189 -178.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.572 ' N ' ' NE2' ' B' ' 68' ' ' HIS . . . 94.6 13.84 52.26 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 121.149 -0.548 . . . . 19.739999999999998 113.668 177.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -90.15 144.9 25.46 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 120.186 -0.606 . . . . 21.93 109.71 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.5 m -117.98 127.91 54.28 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.035 -0.728 . . . . 12.33 109.035 178.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mt -111.59 138.95 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 109.887 -0.412 . . . . 17.079999999999998 109.887 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.2 m -105.08 132.03 51.83 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.722 -0.844 . . . . 16.300000000000001 108.722 178.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.1 mt -127.33 150.3 49.65 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.567 0.222 . . . . 15.880000000000001 110.544 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.417 ' HB2' HE22 ' A' ' 2' ' ' GLN . 86.5 tt0 -100.95 122.19 43.06 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 106.369 -1.715 . . . . 28.899999999999999 106.369 176.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.8 m -140.05 168.0 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 121.612 0.72 . . . . 12.050000000000001 111.854 -178.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -118.5 150.88 48.87 Favored Pre-proline 0 CA--C 1.532 0.266 0 N-CA-C 107.17 -1.418 . . . . 18.170000000000002 107.17 177.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -58.11 -24.27 65.45 Favored 'Trans proline' 0 C--N 1.318 -1.063 0 CA-C-N 120.918 1.364 . . . . 8.1600000000000001 112.728 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.9 p -85.24 -1.83 57.37 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 112.069 0.396 . . . . 11.130000000000001 112.069 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -70.41 143.27 51.9 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 107.939 -1.134 . . . . 18.030000000000001 107.939 178.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.49 ' HG1' ' CG ' ' A' ' 25' ' ' ASN . 71.9 p -86.29 157.21 19.97 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.263 -1.335 . . . . 10.220000000000001 109.912 178.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.1 mm -61.95 -39.77 84.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.72 -0.673 . . . . 12.300000000000001 109.273 178.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -59.99 -38.32 82.26 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 108.724 -0.843 . . . . 36.509999999999998 108.724 178.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.49 ' CG ' ' HG1' ' A' ' 22' ' ' THR . 7.4 m-20 -66.17 -40.05 90.2 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.174 -0.676 . . . . 25.66 109.174 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.6 t -62.95 -43.67 99.15 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 N-CA-C 109.859 -0.423 . . . . 8.1199999999999992 109.859 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.7 mttm -60.08 -39.95 87.89 Favored 'General case' 0 C--N 1.341 0.238 0 N-CA-C 109.243 -0.651 . . . . 15.470000000000001 109.243 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.46 -37.87 87.57 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.74 -0.663 . . . . 11.449999999999999 110.338 -179.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.1 mttm -65.73 -38.94 90.56 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.76 -0.459 . . . . 24.98 109.76 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.3 mt -64.98 -39.95 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 109.669 -0.493 . . . . 9.4600000000000009 109.669 177.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -60.13 -44.12 95.17 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.317 -0.623 . . . . 14.76 109.317 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 53.7 t0 -60.38 -40.51 91.1 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.038 -0.983 . . . . 26.289999999999999 110.75 -178.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.0 mttt -81.76 -40.29 22.86 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 114.317 1.229 . . . . 30.059999999999999 114.317 -177.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -110.71 -15.05 13.92 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 116.277 1.954 . . . . 25.190000000000001 116.277 -174.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.43 11.18 82.44 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 120.951 -0.642 . . . . 7.4100000000000001 113.126 178.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.6 mt -86.41 116.94 67.74 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 109.757 -0.46 . . . . 9.4900000000000002 109.757 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -58.77 134.85 63.21 Favored 'Trans proline' 0 N--CA 1.497 1.709 0 CA-C-N 120.393 1.176 . . . . 11.42 112.142 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -49.4 -31.39 23.21 Favored 'Trans proline' 0 N--CA 1.505 2.184 0 C-N-CA 122.629 2.219 . . . . 12.0 114.407 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -71.05 -16.24 62.59 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 118.625 0.648 . . . . 35.549999999999997 112.106 -178.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -100.02 1.77 42.79 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 111.758 0.281 . . . . 20.52 111.758 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -107.98 139.47 42.56 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.884 1.068 . . . . 7.1299999999999999 113.884 -177.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 1.214 ' NH1' HH22 ' B' ' 42' ' ' ARG . 86.0 mtt180 -126.14 123.87 39.24 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 114.736 -1.12 . . . . 36.390000000000001 108.212 176.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.8 mt -105.67 130.09 53.77 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.309 0.576 . . . . 9.5500000000000007 110.924 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.5 mp -123.18 138.1 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 115.235 -0.893 . . . . 13.9 110.542 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 94.2 t80 -139.34 127.06 21.92 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.207 -0.906 . . . . 6.8600000000000003 108.819 177.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.99 39.13 18.14 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.07 -0.514 . . . . 11.15 111.438 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.08 0.04 89.17 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-O 119.242 -0.755 . . . . 13.93 114.809 176.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.4 mtmt -112.24 139.27 47.92 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 118.817 1.309 . . . . 23.920000000000002 111.805 -178.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -79.38 128.93 33.96 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 107.609 -1.256 . . . . 23.23 107.609 178.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 46.7 mt -86.89 136.55 32.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.844 0.354 . . . . 9.1099999999999994 111.575 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -91.2 149.95 21.56 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.236 0.541 . . . . 33.439999999999998 111.983 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -68.81 -20.09 64.31 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.094 -0.957 . . . . 28.370000000000001 113.577 -177.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.05 3.52 70.19 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 121.13 -0.557 . . . . 15.0 113.079 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.7 mmt-85 -110.12 165.93 11.36 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 117.61 0.705 . . . . 25.5 111.287 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.5 p -107.56 167.34 10.02 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 121.52 0.676 . . . . 11.949999999999999 111.939 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.3 mt -59.94 -42.97 95.16 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 114.831 -1.077 . . . . 10.17 110.952 178.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 84.2 p -61.87 -30.25 70.74 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 119.65 -0.82 . . . . 13.59 111.962 -178.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -62.08 -29.03 70.03 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.712 -0.395 . . . . 11.699999999999999 110.498 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -99.88 13.77 32.68 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.237 -0.438 . . . . 12.949999999999999 111.668 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 50.05 39.98 20.38 Favored 'General case' 0 C--N 1.334 -0.088 0 N-CA-C 112.103 0.409 . . . . 25.449999999999999 112.103 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.2 mt -81.02 121.52 34.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 107.382 -1.34 . . . . 14.6 107.382 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -107.43 169.18 8.73 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.341 0.591 . . . . 33.229999999999997 112.027 -177.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.6 pttt -51.23 141.23 15.11 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.134 -0.939 . . . . 25.969999999999999 111.63 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 66.72 23.38 10.19 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 114.733 -1.121 . . . . 32.609999999999999 112.959 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.0 m -76.82 148.66 36.44 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.018 -1.104 . . . . 10.56 108.018 176.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.0 m -112.81 124.09 51.8 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 109.534 -0.543 . . . . 5.3300000000000001 109.534 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.0 mp -105.2 157.41 17.3 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.63 -1.248 . . . . 11.66 107.63 177.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 1.31 ' CD2' HD23 ' B' ' 8' ' ' LEU . 77.5 m80 -112.26 134.11 53.99 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.234 -0.654 . . . . 16.300000000000001 109.234 179.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 26.5 tp -106.2 132.7 51.95 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.935 -0.765 . . . . 9.9600000000000009 108.935 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 1.046 HG22 HG11 ' B' ' 70' ' ' VAL . 2.6 t -120.73 144.86 28.3 Favored 'Isoleucine or valine' 0 C--N 1.344 0.329 0 N-CA-C 107.588 -1.264 . . . . 9.7599999999999998 107.588 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.735 HD11 ' HA2' ' B' ' 47' ' ' GLY . 41.7 mt -109.89 140.03 44.32 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.353 -0.839 . . . . 19.57 110.583 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.6 ttt180 . . . . . 0 N--CA 1.464 0.241 0 CA-C-N 115.729 -0.669 . . . . 35.079999999999998 110.031 -179.915 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ptt? . . . . . 0 N--CA 1.492 1.629 0 N-CA-C 109.572 -0.529 . . . . 17.170000000000002 109.572 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . 0.411 HE22 ' HB2' ' B' ' 16' ' ' GLU . 67.2 mm-40 -95.87 142.32 28.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.484 0.659 . . . . 21.890000000000001 110.249 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . 0.406 HG22 HD13 ' B' ' 3' ' ' ILE . 45.1 pt -131.45 165.42 31.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 114.938 -1.028 . . . . 10.83 108.312 178.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -124.42 139.99 53.37 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.747 0.308 . . . . 10.609999999999999 111.259 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 41.3 t -122.93 123.77 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 108.608 -0.886 . . . . 9.1300000000000008 108.608 177.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 37.8 mttp -100.02 142.31 31.67 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.9 0.381 . . . . 20.550000000000001 110.475 179.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 27.5 p -101.82 166.04 10.87 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-O 122.046 0.927 . . . . 11.779999999999999 111.093 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 1.31 HD23 ' CD2' ' A' ' 68' ' ' HIS . 86.4 mt -63.96 -19.65 65.3 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 113.657 -1.611 . . . . 19.309999999999999 111.188 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 43.7 p -93.28 -0.02 56.86 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.164 0.431 . . . . 23.140000000000001 112.164 -178.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.56 13.84 52.34 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 121.167 -0.54 . . . . 19.739999999999998 113.712 177.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -90.15 144.89 25.46 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 120.161 -0.616 . . . . 21.93 109.723 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 94.4 m -117.97 127.87 54.25 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 109.074 -0.713 . . . . 12.33 109.074 178.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mt -111.51 139.0 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 109.934 -0.395 . . . . 17.079999999999998 109.934 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 88.6 m -105.15 131.99 51.93 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.755 -0.831 . . . . 16.300000000000001 108.755 178.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 61.9 mt -127.25 150.27 49.63 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.535 0.207 . . . . 15.880000000000001 110.584 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . 0.411 ' HB2' HE22 ' B' ' 2' ' ' GLN . 86.4 tt0 -100.91 122.18 43.02 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 106.351 -1.722 . . . . 28.899999999999999 106.351 176.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 35.7 m -140.04 168.0 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-O 121.587 0.708 . . . . 12.050000000000001 111.852 -178.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -118.47 150.86 48.78 Favored Pre-proline 0 CA--C 1.533 0.301 0 N-CA-C 107.173 -1.417 . . . . 18.170000000000002 107.173 177.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -58.15 -24.24 65.6 Favored 'Trans proline' 0 C--N 1.317 -1.131 0 CA-C-N 120.925 1.366 . . . . 8.1600000000000001 112.687 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 21.2 p -85.23 -1.79 57.32 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 112.096 0.406 . . . . 11.130000000000001 112.096 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -70.47 143.29 51.79 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 107.926 -1.138 . . . . 18.030000000000001 107.926 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' THR . . . . . 0.489 ' HG1' ' CG ' ' B' ' 25' ' ' ASN . 70.1 p -86.25 157.21 20.0 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 114.226 -1.352 . . . . 10.220000000000001 109.947 178.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 35.2 mm -61.99 -39.75 84.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.742 -0.663 . . . . 12.300000000000001 109.305 178.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -59.99 -38.33 82.29 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 108.717 -0.845 . . . . 36.509999999999998 108.717 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' ASN . . . . . 0.489 ' CG ' ' HG1' ' B' ' 22' ' ' THR . 7.4 m-20 -66.14 -40.03 90.28 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.215 -0.661 . . . . 25.66 109.215 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 79.3 t -62.97 -43.68 99.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 N-CA-C 109.831 -0.433 . . . . 8.1199999999999992 109.831 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 24.7 mttm -60.06 -39.97 87.84 Favored 'General case' 0 C--N 1.342 0.275 0 N-CA-C 109.262 -0.644 . . . . 15.470000000000001 109.262 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.39 -37.87 87.44 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.734 -0.667 . . . . 11.449999999999999 110.38 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 34.1 mttm -65.73 -38.97 90.6 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.744 -0.465 . . . . 24.98 109.744 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 44.9 mt -64.99 -40.04 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 109.597 -0.52 . . . . 9.4600000000000009 109.597 177.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -60.06 -44.13 94.93 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.321 -0.622 . . . . 14.76 109.321 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . 0.424 ' O ' ' OD1' ' B' ' 32' ' ' ASP . 53.6 t0 -60.37 -40.58 91.32 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.032 -0.986 . . . . 26.289999999999999 110.724 -178.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 24.0 mttt -81.69 -40.25 23.1 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 114.409 1.263 . . . . 30.059999999999999 114.409 -177.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -110.77 -14.91 13.93 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 116.309 1.966 . . . . 25.190000000000001 116.309 -174.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.42 11.18 82.45 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 120.974 -0.631 . . . . 7.4100000000000001 113.068 178.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 16.6 mt -86.45 116.99 67.93 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 109.753 -0.462 . . . . 9.4900000000000002 109.753 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -58.8 134.83 62.96 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 CA-C-N 120.435 1.191 . . . . 11.42 112.122 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -49.42 -31.34 23.2 Favored 'Trans proline' 0 N--CA 1.505 2.172 0 C-N-CA 122.61 2.206 . . . . 12.0 114.412 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -71.05 -16.28 62.59 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 118.655 0.662 . . . . 35.549999999999997 112.107 -178.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -99.99 1.78 42.88 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 111.742 0.275 . . . . 20.52 111.742 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -107.95 139.47 42.52 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.892 1.071 . . . . 7.1299999999999999 113.892 -177.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . 1.214 HH22 ' NH1' ' A' ' 42' ' ' ARG . 86.0 mtt180 -126.21 123.9 39.24 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 114.766 -1.106 . . . . 36.390000000000001 108.17 176.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 90.7 mt -105.69 130.09 53.77 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.307 0.575 . . . . 9.5500000000000007 110.893 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 1.622 ' CB ' HD11 ' A' ' 8' ' ' LEU . 1.5 mp -123.16 138.08 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 115.193 -0.912 . . . . 13.9 110.503 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 94.2 t80 -139.31 127.07 21.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.274 -0.876 . . . . 6.8600000000000003 108.921 177.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.02 39.17 18.33 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.121 -0.49 . . . . 11.15 111.424 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . 0.735 ' HA2' HD11 ' A' ' 71' ' ' LEU . . . 82.02 -0.0 89.06 Favored Glycine 0 CA--C 1.532 1.107 0 N-CA-C 114.9 0.72 . . . . 13.93 114.9 176.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 35.4 mtmt -112.2 139.26 47.88 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 118.769 1.284 . . . . 23.920000000000002 111.748 -178.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . 0.534 ' HB2' ' O ' ' A' ' 71' ' ' LEU . 27.7 tt0 -79.35 128.96 33.99 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 107.645 -1.243 . . . . 23.23 107.645 178.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 46.9 mt -86.95 136.52 32.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.874 0.369 . . . . 9.1099999999999994 111.53 -178.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -91.17 149.91 21.59 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.207 0.527 . . . . 33.439999999999998 112.003 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -68.83 -20.06 64.29 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.542 0.941 . . . . 28.370000000000001 113.542 -177.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.97 3.42 70.34 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 121.166 -0.54 . . . . 15.0 113.11 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 68.6 mmt-85 -110.05 165.91 11.36 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 117.644 0.722 . . . . 25.5 111.292 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 71.2 p -107.52 167.37 9.99 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-O 121.553 0.692 . . . . 11.949999999999999 111.965 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 91.3 mt -59.99 -42.94 95.31 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 114.843 -1.071 . . . . 10.17 110.951 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 84.1 p -61.86 -30.34 70.79 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 119.685 -0.806 . . . . 13.59 111.91 -178.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -62.07 -28.96 69.98 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.652 -0.419 . . . . 11.699999999999999 110.495 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -99.92 13.81 32.6 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.274 -0.421 . . . . 12.949999999999999 111.646 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 50.0 40.08 20.4 Favored 'General case' 0 C--O 1.231 0.11 0 N-CA-C 112.034 0.383 . . . . 25.449999999999999 112.034 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 91.0 mt -81.11 121.49 34.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 107.36 -1.348 . . . . 14.6 107.36 178.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -107.45 169.15 8.76 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.309 0.576 . . . . 33.229999999999997 112.069 -177.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 52.6 pttt -51.13 141.21 14.73 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.103 -0.953 . . . . 25.969999999999999 111.639 -178.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 66.77 23.31 10.13 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 114.752 -1.113 . . . . 32.609999999999999 112.941 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 37.0 m -76.83 148.67 36.42 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.009 -1.108 . . . . 10.56 108.009 176.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 93.9 m -112.79 124.08 51.78 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 109.54 -0.541 . . . . 5.3300000000000001 109.54 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 4.0 mp -105.19 157.35 17.34 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 107.642 -1.244 . . . . 11.66 107.642 177.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . 1.657 ' CE1' ' HA ' ' A' ' 9' ' ' THR . 77.5 m80 -112.18 134.09 53.93 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.232 -0.655 . . . . 16.300000000000001 109.232 179.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 26.7 tp -106.21 132.72 51.93 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.895 -0.78 . . . . 9.9600000000000009 108.895 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . 1.046 HG11 HG22 ' A' ' 70' ' ' VAL . 2.6 t -120.74 144.85 28.34 Favored 'Isoleucine or valine' 0 C--N 1.344 0.334 0 N-CA-C 107.561 -1.274 . . . . 9.7599999999999998 107.561 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 41.3 mt -109.88 140.03 44.29 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.33 -0.85 . . . . 19.57 110.615 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 36.6 ttt180 . . . . . 0 N--CA 1.465 0.285 0 CA-C-N 115.69 -0.686 . . . . 35.079999999999998 110.0 -179.918 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ptt? . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 109.542 -0.54 . . . . 17.17 109.542 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.436 HE22 ' HB2' ' A' ' 16' ' ' GLU . 67.1 mm-40 -95.82 142.34 28.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.434 0.635 . . . . 21.89 110.264 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.1 pt -131.49 165.4 31.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 114.905 -1.043 . . . . 10.83 108.29 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -124.37 139.94 53.43 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.703 0.287 . . . . 10.61 111.277 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.2 t -122.88 123.72 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 108.594 -0.891 . . . . 9.13 108.594 177.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.9 mttp -100.03 142.31 31.68 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.864 0.364 . . . . 20.55 110.507 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.4 p -101.83 166.07 10.86 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-O 122.099 0.952 . . . . 11.78 111.047 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.578 ' CD1' HG12 ' B' ' 44' ' ' ILE . 86.3 mt -64.03 -19.58 65.3 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.61 -1.632 . . . . 19.31 111.189 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . 1.657 ' HA ' ' CE1' ' B' ' 68' ' ' HIS . 43.8 p -93.34 0.01 56.77 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.189 0.44 . . . . 23.14 112.189 -178.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.572 ' N ' ' NE2' ' B' ' 68' ' ' HIS . . . 94.6 13.84 52.26 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 121.149 -0.548 . . . . 19.74 113.668 177.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -90.15 144.9 25.46 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 120.186 -0.606 . . . . 21.93 109.71 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.5 m -117.98 127.91 54.28 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.035 -0.728 . . . . 12.33 109.035 178.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mt -111.59 138.95 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 109.887 -0.412 . . . . 17.08 109.887 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.2 m -105.08 132.03 51.83 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.722 -0.844 . . . . 16.3 108.722 178.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.1 mt -127.33 150.3 49.65 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.567 0.222 . . . . 15.88 110.544 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.436 ' HB2' HE22 ' A' ' 2' ' ' GLN . 86.5 tt0 -100.95 122.19 43.06 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 106.369 -1.715 . . . . 28.9 106.369 176.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.8 m -140.05 168.0 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 121.612 0.72 . . . . 12.05 111.854 -178.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -118.5 150.88 48.87 Favored Pre-proline 0 CA--C 1.532 0.266 0 N-CA-C 107.17 -1.418 . . . . 18.17 107.17 177.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -58.11 -24.27 65.45 Favored 'Trans proline' 0 C--N 1.318 -1.063 0 CA-C-N 120.918 1.364 . . . . 8.16 112.728 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.9 p -85.24 -1.83 57.37 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 112.069 0.396 . . . . 11.13 112.069 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -70.41 143.27 51.9 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 107.939 -1.134 . . . . 18.03 107.939 178.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.41 ' OG1' ' OD1' ' A' ' 25' ' ' ASN . 71.9 p -86.29 157.21 19.97 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.263 -1.335 . . . . 10.22 109.912 178.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.1 mm -61.95 -39.77 84.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.72 -0.673 . . . . 12.3 109.273 178.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -59.99 -38.32 82.26 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 108.724 -0.843 . . . . 36.51 108.724 178.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.41 ' OD1' ' OG1' ' A' ' 22' ' ' THR . 7.4 m-20 -66.17 -40.05 90.2 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.174 -0.676 . . . . 25.66 109.174 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.6 t -62.95 -43.67 99.15 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 N-CA-C 109.859 -0.423 . . . . 8.12 109.859 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.7 mttm -60.08 -39.95 87.89 Favored 'General case' 0 C--N 1.341 0.238 0 N-CA-C 109.243 -0.651 . . . . 15.47 109.243 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.46 -37.87 87.57 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.74 -0.663 . . . . 11.45 110.338 -179.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.1 mttm -65.73 -38.94 90.56 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.76 -0.459 . . . . 24.98 109.76 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.3 mt -64.98 -39.95 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 109.669 -0.493 . . . . 9.46 109.669 177.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -60.13 -44.12 95.17 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.317 -0.623 . . . . 14.76 109.317 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 32' ' ' ASP . 53.7 t0 -60.38 -40.51 91.1 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.038 -0.983 . . . . 26.29 110.75 -178.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.0 mttt -81.76 -40.29 22.86 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 114.317 1.229 . . . . 30.06 114.317 -177.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -110.71 -15.05 13.92 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 116.277 1.954 . . . . 25.19 116.277 -174.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.43 11.18 82.44 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 120.951 -0.642 . . . . 7.41 113.126 178.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.6 mt -86.41 116.94 67.74 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 109.757 -0.46 . . . . 9.49 109.757 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -58.77 134.85 63.21 Favored 'Trans proline' 0 N--CA 1.497 1.709 0 CA-C-N 120.393 1.176 . . . . 11.42 112.142 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -49.4 -31.39 23.21 Favored 'Trans proline' 0 N--CA 1.505 2.184 0 C-N-CA 122.629 2.219 . . . . 12.0 114.407 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -71.05 -16.24 62.59 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 118.625 0.648 . . . . 35.55 112.106 -178.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -100.02 1.77 42.79 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 111.758 0.281 . . . . 20.52 111.758 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -107.98 139.47 42.56 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.884 1.068 . . . . 7.13 113.884 -177.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 1.224 ' NH1' HH22 ' B' ' 42' ' ' ARG . 86.0 mtt180 -126.14 123.87 39.24 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 114.736 -1.12 . . . . 36.39 108.212 176.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.8 mt -105.67 130.09 53.77 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.309 0.576 . . . . 9.55 110.924 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.5 mp -123.18 138.1 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 115.235 -0.893 . . . . 13.9 110.542 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 94.2 t80 -139.34 127.06 21.92 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.207 -0.906 . . . . 6.86 108.819 177.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.99 39.13 18.14 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.07 -0.514 . . . . 11.15 111.438 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.08 0.04 89.17 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-O 119.242 -0.755 . . . . 13.93 114.809 176.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.4 mtmt -112.24 139.27 47.92 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 118.817 1.309 . . . . 23.92 111.805 -178.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -79.38 128.93 33.96 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 107.609 -1.256 . . . . 23.23 107.609 178.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 46.7 mt -86.89 136.55 32.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.844 0.354 . . . . 9.11 111.575 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -91.2 149.95 21.56 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.236 0.541 . . . . 33.44 111.983 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -68.81 -20.09 64.31 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.094 -0.957 . . . . 28.37 113.577 -177.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.05 3.52 70.19 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 121.13 -0.557 . . . . 15.0 113.079 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.7 mmt-85 -110.12 165.93 11.36 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 117.61 0.705 . . . . 25.5 111.287 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.5 p -107.56 167.34 10.02 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 121.52 0.676 . . . . 11.95 111.939 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.3 mt -59.94 -42.97 95.16 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 114.831 -1.077 . . . . 10.17 110.952 178.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 84.2 p -61.87 -30.25 70.74 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 119.65 -0.82 . . . . 13.59 111.962 -178.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -62.08 -29.03 70.03 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.712 -0.395 . . . . 11.7 110.498 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -99.88 13.77 32.68 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.237 -0.438 . . . . 12.95 111.668 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 50.05 39.98 20.38 Favored 'General case' 0 C--N 1.334 -0.088 0 N-CA-C 112.103 0.409 . . . . 25.45 112.103 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.2 mt -81.02 121.52 34.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 107.382 -1.34 . . . . 14.6 107.382 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -107.43 169.18 8.73 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.341 0.591 . . . . 33.23 112.027 -177.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.6 pttt -51.23 141.23 15.11 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.134 -0.939 . . . . 25.97 111.63 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 66.72 23.38 10.19 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 114.733 -1.121 . . . . 32.61 112.959 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.0 m -76.82 148.66 36.44 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.018 -1.104 . . . . 10.56 108.018 176.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.0 m -112.81 124.09 51.8 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 109.534 -0.543 . . . . 5.33 109.534 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.421 HD12 ' N ' ' A' ' 67' ' ' LEU . 4.0 mp -105.2 157.41 17.3 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.63 -1.248 . . . . 11.66 107.63 177.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 1.393 ' CD2' HD22 ' B' ' 8' ' ' LEU . 77.5 m80 -112.26 134.11 53.99 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.234 -0.654 . . . . 16.3 109.234 179.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 26.5 tp -106.2 132.7 51.95 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.935 -0.765 . . . . 9.96 108.935 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.025 HG21 HG11 ' B' ' 70' ' ' VAL . 2.6 t -120.73 144.86 28.3 Favored 'Isoleucine or valine' 0 C--N 1.344 0.329 0 N-CA-C 107.588 -1.264 . . . . 9.76 107.588 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.743 HD12 ' HA2' ' B' ' 47' ' ' GLY . 41.7 mt -109.89 140.03 44.32 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.353 -0.839 . . . . 19.57 110.583 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.6 ttt180 . . . . . 0 N--CA 1.464 0.241 0 CA-C-N 115.729 -0.669 . . . . 35.08 110.031 -179.915 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ptt? . . . . . 0 N--CA 1.492 1.629 0 N-CA-C 109.572 -0.529 . . . . 17.17 109.572 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' GLN . . . . . 0.432 HE22 ' HB2' ' B' ' 16' ' ' GLU . 67.2 mm-40 -95.87 142.32 28.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.484 0.659 . . . . 21.89 110.249 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 45.1 pt -131.45 165.42 31.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 114.938 -1.028 . . . . 10.83 108.312 178.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -124.42 139.99 53.37 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.747 0.308 . . . . 10.61 111.259 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 41.3 t -122.93 123.77 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 108.608 -0.886 . . . . 9.13 108.608 177.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 37.8 mttp -100.02 142.31 31.67 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.9 0.381 . . . . 20.55 110.475 179.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 27.5 p -101.82 166.04 10.87 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-O 122.046 0.927 . . . . 11.78 111.093 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 1.393 HD22 ' CD2' ' A' ' 68' ' ' HIS . 86.4 mt -63.96 -19.65 65.3 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 113.657 -1.611 . . . . 19.31 111.188 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 43.7 p -93.28 -0.02 56.86 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.164 0.431 . . . . 23.14 112.164 -178.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.56 13.84 52.34 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 121.167 -0.54 . . . . 19.74 113.712 177.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -90.15 144.89 25.46 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 120.161 -0.616 . . . . 21.93 109.723 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 94.4 m -117.97 127.87 54.25 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 109.074 -0.713 . . . . 12.33 109.074 178.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mt -111.51 139.0 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 109.934 -0.395 . . . . 17.08 109.934 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 88.6 m -105.15 131.99 51.93 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.755 -0.831 . . . . 16.3 108.755 178.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 61.9 mt -127.25 150.27 49.63 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.535 0.207 . . . . 15.88 110.584 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 16' ' ' GLU . . . . . 0.432 ' HB2' HE22 ' B' ' 2' ' ' GLN . 86.4 tt0 -100.91 122.18 43.02 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 106.351 -1.722 . . . . 28.9 106.351 176.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 35.7 m -140.04 168.0 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-O 121.587 0.708 . . . . 12.05 111.852 -178.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -118.47 150.86 48.78 Favored Pre-proline 0 CA--C 1.533 0.301 0 N-CA-C 107.173 -1.417 . . . . 18.17 107.173 177.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -58.15 -24.24 65.6 Favored 'Trans proline' 0 C--N 1.317 -1.131 0 CA-C-N 120.925 1.366 . . . . 8.16 112.687 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 21.2 p -85.23 -1.79 57.32 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 112.096 0.406 . . . . 11.13 112.096 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -70.47 143.29 51.79 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 107.926 -1.138 . . . . 18.03 107.926 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 22' ' ' THR . . . . . 0.406 ' OG1' ' OD1' ' B' ' 25' ' ' ASN . 70.1 p -86.25 157.21 20.0 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 114.226 -1.352 . . . . 10.22 109.947 178.293 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 35.2 mm -61.99 -39.75 84.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.742 -0.663 . . . . 12.3 109.305 178.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -59.99 -38.33 82.29 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 108.717 -0.845 . . . . 36.51 108.717 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' ASN . . . . . 0.406 ' OD1' ' OG1' ' B' ' 22' ' ' THR . 7.4 m-20 -66.14 -40.03 90.28 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.215 -0.661 . . . . 25.66 109.215 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 79.3 t -62.97 -43.68 99.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 N-CA-C 109.831 -0.433 . . . . 8.12 109.831 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 24.7 mttm -60.06 -39.97 87.84 Favored 'General case' 0 C--N 1.342 0.275 0 N-CA-C 109.262 -0.644 . . . . 15.47 109.262 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.39 -37.87 87.44 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.734 -0.667 . . . . 11.45 110.38 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 34.1 mttm -65.73 -38.97 90.6 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.744 -0.465 . . . . 24.98 109.744 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 44.9 mt -64.99 -40.04 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 109.597 -0.52 . . . . 9.46 109.597 177.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -60.06 -44.13 94.93 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.321 -0.622 . . . . 14.76 109.321 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 32' ' ' ASP . . . . . 0.424 ' O ' ' OD1' ' B' ' 32' ' ' ASP . 53.6 t0 -60.37 -40.58 91.32 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.032 -0.986 . . . . 26.29 110.724 -178.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 24.0 mttt -81.69 -40.25 23.1 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 114.409 1.263 . . . . 30.06 114.409 -177.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -110.77 -14.91 13.93 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 116.309 1.966 . . . . 25.19 116.309 -174.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.42 11.18 82.45 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 120.974 -0.631 . . . . 7.41 113.068 178.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 16.6 mt -86.45 116.99 67.93 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 109.753 -0.462 . . . . 9.49 109.753 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -58.8 134.83 62.96 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 CA-C-N 120.435 1.191 . . . . 11.42 112.122 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -49.42 -31.34 23.2 Favored 'Trans proline' 0 N--CA 1.505 2.172 0 C-N-CA 122.61 2.206 . . . . 12.0 114.412 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -71.05 -16.28 62.59 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 118.655 0.662 . . . . 35.55 112.107 -178.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -99.99 1.78 42.88 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 111.742 0.275 . . . . 20.52 111.742 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -107.95 139.47 42.52 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.892 1.071 . . . . 7.13 113.892 -177.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 42' ' ' ARG . . . . . 1.224 HH22 ' NH1' ' A' ' 42' ' ' ARG . 86.0 mtt180 -126.21 123.9 39.24 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 114.766 -1.106 . . . . 36.39 108.17 176.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 90.7 mt -105.69 130.09 53.77 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.307 0.575 . . . . 9.55 110.893 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 1.578 HG12 ' CD1' ' A' ' 8' ' ' LEU . 1.5 mp -123.16 138.08 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 115.193 -0.912 . . . . 13.9 110.503 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 94.2 t80 -139.31 127.07 21.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.274 -0.876 . . . . 6.86 108.921 177.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.02 39.17 18.33 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.121 -0.49 . . . . 11.15 111.424 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 47' ' ' GLY . . . . . 0.743 ' HA2' HD12 ' A' ' 71' ' ' LEU . . . 82.02 -0.0 89.06 Favored Glycine 0 CA--C 1.532 1.107 0 N-CA-C 114.9 0.72 . . . . 13.93 114.9 176.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 35.4 mtmt -112.2 139.26 47.88 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 118.769 1.284 . . . . 23.92 111.748 -178.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 49' ' ' GLN . . . . . 0.55 ' HB2' ' O ' ' A' ' 71' ' ' LEU . 27.7 tt0 -79.35 128.96 33.99 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 107.645 -1.243 . . . . 23.23 107.645 178.16 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 46.9 mt -86.95 136.52 32.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.874 0.369 . . . . 9.11 111.53 -178.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -91.17 149.91 21.59 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.207 0.527 . . . . 33.44 112.003 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -68.83 -20.06 64.29 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.542 0.941 . . . . 28.37 113.542 -177.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.97 3.42 70.34 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 121.166 -0.54 . . . . 15.0 113.11 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 68.6 mmt-85 -110.05 165.91 11.36 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 117.644 0.722 . . . . 25.5 111.292 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 71.2 p -107.52 167.37 9.99 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-O 121.553 0.692 . . . . 11.95 111.965 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 91.3 mt -59.99 -42.94 95.31 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 114.843 -1.071 . . . . 10.17 110.951 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 84.1 p -61.86 -30.34 70.79 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 119.685 -0.806 . . . . 13.59 111.91 -178.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -62.07 -28.96 69.98 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.652 -0.419 . . . . 11.7 110.495 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -99.92 13.81 32.6 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.274 -0.421 . . . . 12.95 111.646 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 50.0 40.08 20.4 Favored 'General case' 0 C--O 1.231 0.11 0 N-CA-C 112.034 0.383 . . . . 25.45 112.034 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 91.0 mt -81.11 121.49 34.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 107.36 -1.348 . . . . 14.6 107.36 178.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -107.45 169.15 8.76 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.309 0.576 . . . . 33.23 112.069 -177.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 52.6 pttt -51.13 141.21 14.73 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.103 -0.953 . . . . 25.97 111.639 -178.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 66.77 23.31 10.13 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 114.752 -1.113 . . . . 32.61 112.941 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 37.0 m -76.83 148.67 36.42 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.009 -1.108 . . . . 10.56 108.009 176.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 93.9 m -112.79 124.08 51.78 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 109.54 -0.541 . . . . 5.33 109.54 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.41 ' N ' HD12 ' B' ' 67' ' ' LEU . 4.0 mp -105.19 157.35 17.34 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 107.642 -1.244 . . . . 11.66 107.642 177.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 68' ' ' HIS . . . . . 1.657 ' CE1' ' HA ' ' A' ' 9' ' ' THR . 77.5 m80 -112.18 134.09 53.93 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.232 -0.655 . . . . 16.3 109.232 179.111 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 26.7 tp -106.21 132.72 51.93 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.895 -0.78 . . . . 9.96 108.895 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 1.025 HG11 HG21 ' A' ' 70' ' ' VAL . 2.6 t -120.74 144.85 28.34 Favored 'Isoleucine or valine' 0 C--N 1.344 0.334 0 N-CA-C 107.561 -1.274 . . . . 9.76 107.561 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 41.3 mt -109.88 140.03 44.29 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.33 -0.85 . . . . 19.57 110.615 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 36.6 ttt180 . . . . . 0 N--CA 1.465 0.285 0 CA-C-N 115.69 -0.686 . . . . 35.08 110.0 -179.918 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ptt? . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 109.542 -0.54 . . . . 17.17 109.542 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.436 HE22 ' HB2' ' A' ' 16' ' ' GLU . 67.1 mm-40 -95.82 142.34 28.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.434 0.635 . . . . 21.89 110.264 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.1 pt -131.49 165.4 31.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 114.905 -1.043 . . . . 10.83 108.29 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -124.37 139.94 53.43 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.703 0.287 . . . . 10.61 111.277 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.2 t -122.88 123.72 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 108.594 -0.891 . . . . 9.13 108.594 177.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.9 mttp -100.03 142.31 31.68 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.864 0.364 . . . . 20.55 110.507 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.4 p -101.83 166.07 10.86 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-O 122.099 0.952 . . . . 11.78 111.047 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.578 ' CD1' HG12 ' B' ' 44' ' ' ILE . 86.3 mt -64.03 -19.58 65.3 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.61 -1.632 . . . . 19.31 111.189 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 1.657 ' HA ' ' CE1' ' B' ' 68' ' ' HIS . 43.8 p -93.34 0.01 56.77 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.189 0.44 . . . . 23.14 112.189 -178.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.572 ' N ' ' NE2' ' B' ' 68' ' ' HIS . . . 94.6 13.84 52.26 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 121.149 -0.548 . . . . 19.74 113.668 177.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -90.15 144.9 25.46 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 120.186 -0.606 . . . . 21.93 109.71 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.5 m -117.98 127.91 54.28 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.035 -0.728 . . . . 12.33 109.035 178.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mt -111.59 138.95 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 109.887 -0.412 . . . . 17.08 109.887 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.2 m -105.08 132.03 51.83 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.722 -0.844 . . . . 16.3 108.722 178.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.1 mt -127.33 150.3 49.65 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.567 0.222 . . . . 15.88 110.544 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.436 ' HB2' HE22 ' A' ' 2' ' ' GLN . 86.5 tt0 -100.95 122.19 43.06 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 106.369 -1.715 . . . . 28.9 106.369 176.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.8 m -140.05 168.0 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 121.612 0.72 . . . . 12.05 111.854 -178.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -118.5 150.88 48.87 Favored Pre-proline 0 CA--C 1.532 0.266 0 N-CA-C 107.17 -1.418 . . . . 18.17 107.17 177.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -58.11 -24.27 65.45 Favored 'Trans proline' 0 C--N 1.318 -1.063 0 CA-C-N 120.918 1.364 . . . . 8.16 112.728 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.9 p -85.24 -1.83 57.37 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 112.069 0.396 . . . . 11.13 112.069 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -70.41 143.27 51.9 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 107.939 -1.134 . . . . 18.03 107.939 178.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.41 ' OG1' ' OD1' ' A' ' 25' ' ' ASN . 71.9 p -86.29 157.21 19.97 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.263 -1.335 . . . . 10.22 109.912 178.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.1 mm -61.95 -39.77 84.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.72 -0.673 . . . . 12.3 109.273 178.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -59.99 -38.32 82.26 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 108.724 -0.843 . . . . 36.51 108.724 178.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.41 ' OD1' ' OG1' ' A' ' 22' ' ' THR . 7.4 m-20 -66.17 -40.05 90.2 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.174 -0.676 . . . . 25.66 109.174 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.6 t -62.95 -43.67 99.15 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 N-CA-C 109.859 -0.423 . . . . 8.12 109.859 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.7 mttm -60.08 -39.95 87.89 Favored 'General case' 0 C--N 1.341 0.238 0 N-CA-C 109.243 -0.651 . . . . 15.47 109.243 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.46 -37.87 87.57 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.74 -0.663 . . . . 11.45 110.338 -179.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.1 mttm -65.73 -38.94 90.56 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.76 -0.459 . . . . 24.98 109.76 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.3 mt -64.98 -39.95 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 109.669 -0.493 . . . . 9.46 109.669 177.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -60.13 -44.12 95.17 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.317 -0.623 . . . . 14.76 109.317 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 32' ' ' ASP . 53.7 t0 -60.38 -40.51 91.1 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.038 -0.983 . . . . 26.29 110.75 -178.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.0 mttt -81.76 -40.29 22.86 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 114.317 1.229 . . . . 30.06 114.317 -177.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -110.71 -15.05 13.92 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 116.277 1.954 . . . . 25.19 116.277 -174.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.43 11.18 82.44 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 120.951 -0.642 . . . . 7.41 113.126 178.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.6 mt -86.41 116.94 67.74 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 109.757 -0.46 . . . . 9.49 109.757 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -58.77 134.85 63.21 Favored 'Trans proline' 0 N--CA 1.497 1.709 0 CA-C-N 120.393 1.176 . . . . 11.42 112.142 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -49.4 -31.39 23.21 Favored 'Trans proline' 0 N--CA 1.505 2.184 0 C-N-CA 122.629 2.219 . . . . 12.0 114.407 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -71.05 -16.24 62.59 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 118.625 0.648 . . . . 35.55 112.106 -178.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -100.02 1.77 42.79 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 111.758 0.281 . . . . 20.52 111.758 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -107.98 139.47 42.56 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.884 1.068 . . . . 7.13 113.884 -177.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 1.224 ' NH1' HH22 ' B' ' 42' ' ' ARG . 86.0 mtt180 -126.14 123.87 39.24 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 114.736 -1.12 . . . . 36.39 108.212 176.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.8 mt -105.67 130.09 53.77 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.309 0.576 . . . . 9.55 110.924 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.5 mp -123.18 138.1 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 115.235 -0.893 . . . . 13.9 110.542 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 94.2 t80 -139.34 127.06 21.92 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.207 -0.906 . . . . 6.86 108.819 177.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.99 39.13 18.14 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.07 -0.514 . . . . 11.15 111.438 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.08 0.04 89.17 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-O 119.242 -0.755 . . . . 13.93 114.809 176.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.4 mtmt -112.24 139.27 47.92 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 118.817 1.309 . . . . 23.92 111.805 -178.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -79.38 128.93 33.96 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 107.609 -1.256 . . . . 23.23 107.609 178.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 46.7 mt -86.89 136.55 32.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.844 0.354 . . . . 9.11 111.575 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -91.2 149.95 21.56 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.236 0.541 . . . . 33.44 111.983 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -68.81 -20.09 64.31 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.094 -0.957 . . . . 28.37 113.577 -177.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.05 3.52 70.19 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 121.13 -0.557 . . . . 15.0 113.079 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.7 mmt-85 -110.12 165.93 11.36 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 117.61 0.705 . . . . 25.5 111.287 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.5 p -107.56 167.34 10.02 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 121.52 0.676 . . . . 11.95 111.939 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.3 mt -59.94 -42.97 95.16 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 114.831 -1.077 . . . . 10.17 110.952 178.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 84.2 p -61.87 -30.25 70.74 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 119.65 -0.82 . . . . 13.59 111.962 -178.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -62.08 -29.03 70.03 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.712 -0.395 . . . . 11.7 110.498 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -99.88 13.77 32.68 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.237 -0.438 . . . . 12.95 111.668 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 50.05 39.98 20.38 Favored 'General case' 0 C--N 1.334 -0.088 0 N-CA-C 112.103 0.409 . . . . 25.45 112.103 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.2 mt -81.02 121.52 34.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 107.382 -1.34 . . . . 14.6 107.382 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -107.43 169.18 8.73 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.341 0.591 . . . . 33.23 112.027 -177.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.6 pttt -51.23 141.23 15.11 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.134 -0.939 . . . . 25.97 111.63 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 66.72 23.38 10.19 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 114.733 -1.121 . . . . 32.61 112.959 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.0 m -76.82 148.66 36.44 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.018 -1.104 . . . . 10.56 108.018 176.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.0 m -112.81 124.09 51.8 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 109.534 -0.543 . . . . 5.33 109.534 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.421 HD12 ' N ' ' A' ' 67' ' ' LEU . 4.0 mp -105.2 157.41 17.3 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.63 -1.248 . . . . 11.66 107.63 177.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 1.393 ' CD2' HD22 ' B' ' 8' ' ' LEU . 77.5 m80 -112.26 134.11 53.99 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.234 -0.654 . . . . 16.3 109.234 179.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 26.5 tp -106.2 132.7 51.95 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.935 -0.765 . . . . 9.96 108.935 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.025 HG21 HG11 ' B' ' 70' ' ' VAL . 2.6 t -120.73 144.86 28.3 Favored 'Isoleucine or valine' 0 C--N 1.344 0.329 0 N-CA-C 107.588 -1.264 . . . . 9.76 107.588 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.743 HD12 ' HA2' ' B' ' 47' ' ' GLY . 41.7 mt -109.89 140.03 44.32 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.353 -0.839 . . . . 19.57 110.583 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.6 ttt180 . . . . . 0 N--CA 1.464 0.241 0 CA-C-N 115.729 -0.669 . . . . 35.08 110.031 -179.915 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ptt? . . . . . 0 N--CA 1.492 1.629 0 N-CA-C 109.572 -0.529 . . . . 17.17 109.572 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . 0.432 HE22 ' HB2' ' B' ' 16' ' ' GLU . 67.2 mm-40 -95.87 142.32 28.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.484 0.659 . . . . 21.89 110.249 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 45.1 pt -131.45 165.42 31.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 114.938 -1.028 . . . . 10.83 108.312 178.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -124.42 139.99 53.37 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.747 0.308 . . . . 10.61 111.259 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 41.3 t -122.93 123.77 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 108.608 -0.886 . . . . 9.13 108.608 177.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 37.8 mttp -100.02 142.31 31.67 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.9 0.381 . . . . 20.55 110.475 179.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 27.5 p -101.82 166.04 10.87 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-O 122.046 0.927 . . . . 11.78 111.093 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 1.393 HD22 ' CD2' ' A' ' 68' ' ' HIS . 86.4 mt -63.96 -19.65 65.3 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 113.657 -1.611 . . . . 19.31 111.188 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 43.7 p -93.28 -0.02 56.86 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.164 0.431 . . . . 23.14 112.164 -178.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.56 13.84 52.34 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 121.167 -0.54 . . . . 19.74 113.712 177.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -90.15 144.89 25.46 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 120.161 -0.616 . . . . 21.93 109.723 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 94.4 m -117.97 127.87 54.25 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 109.074 -0.713 . . . . 12.33 109.074 178.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mt -111.51 139.0 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 109.934 -0.395 . . . . 17.08 109.934 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 88.6 m -105.15 131.99 51.93 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.755 -0.831 . . . . 16.3 108.755 178.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 61.9 mt -127.25 150.27 49.63 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.535 0.207 . . . . 15.88 110.584 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . 0.432 ' HB2' HE22 ' B' ' 2' ' ' GLN . 86.4 tt0 -100.91 122.18 43.02 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 106.351 -1.722 . . . . 28.9 106.351 176.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 35.7 m -140.04 168.0 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-O 121.587 0.708 . . . . 12.05 111.852 -178.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -118.47 150.86 48.78 Favored Pre-proline 0 CA--C 1.533 0.301 0 N-CA-C 107.173 -1.417 . . . . 18.17 107.173 177.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -58.15 -24.24 65.6 Favored 'Trans proline' 0 C--N 1.317 -1.131 0 CA-C-N 120.925 1.366 . . . . 8.16 112.687 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 21.2 p -85.23 -1.79 57.32 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 112.096 0.406 . . . . 11.13 112.096 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -70.47 143.29 51.79 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 107.926 -1.138 . . . . 18.03 107.926 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . 0.406 ' OG1' ' OD1' ' B' ' 25' ' ' ASN . 70.1 p -86.25 157.21 20.0 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 114.226 -1.352 . . . . 10.22 109.947 178.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 35.2 mm -61.99 -39.75 84.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.742 -0.663 . . . . 12.3 109.305 178.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -59.99 -38.33 82.29 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 108.717 -0.845 . . . . 36.51 108.717 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' ASN . . . . . 0.406 ' OD1' ' OG1' ' B' ' 22' ' ' THR . 7.4 m-20 -66.14 -40.03 90.28 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.215 -0.661 . . . . 25.66 109.215 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 79.3 t -62.97 -43.68 99.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 N-CA-C 109.831 -0.433 . . . . 8.12 109.831 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 24.7 mttm -60.06 -39.97 87.84 Favored 'General case' 0 C--N 1.342 0.275 0 N-CA-C 109.262 -0.644 . . . . 15.47 109.262 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.39 -37.87 87.44 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.734 -0.667 . . . . 11.45 110.38 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 34.1 mttm -65.73 -38.97 90.6 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.744 -0.465 . . . . 24.98 109.744 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 44.9 mt -64.99 -40.04 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 109.597 -0.52 . . . . 9.46 109.597 177.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -60.06 -44.13 94.93 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.321 -0.622 . . . . 14.76 109.321 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . 0.424 ' O ' ' OD1' ' B' ' 32' ' ' ASP . 53.6 t0 -60.37 -40.58 91.32 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.032 -0.986 . . . . 26.29 110.724 -178.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 24.0 mttt -81.69 -40.25 23.1 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 114.409 1.263 . . . . 30.06 114.409 -177.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -110.77 -14.91 13.93 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 116.309 1.966 . . . . 25.19 116.309 -174.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.42 11.18 82.45 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 120.974 -0.631 . . . . 7.41 113.068 178.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 16.6 mt -86.45 116.99 67.93 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 109.753 -0.462 . . . . 9.49 109.753 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -58.8 134.83 62.96 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 CA-C-N 120.435 1.191 . . . . 11.42 112.122 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -49.42 -31.34 23.2 Favored 'Trans proline' 0 N--CA 1.505 2.172 0 C-N-CA 122.61 2.206 . . . . 12.0 114.412 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -71.05 -16.28 62.59 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 118.655 0.662 . . . . 35.55 112.107 -178.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -99.99 1.78 42.88 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 111.742 0.275 . . . . 20.52 111.742 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -107.95 139.47 42.52 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.892 1.071 . . . . 7.13 113.892 -177.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . 1.224 HH22 ' NH1' ' A' ' 42' ' ' ARG . 86.0 mtt180 -126.21 123.9 39.24 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 114.766 -1.106 . . . . 36.39 108.17 176.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 90.7 mt -105.69 130.09 53.77 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.307 0.575 . . . . 9.55 110.893 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 1.578 HG12 ' CD1' ' A' ' 8' ' ' LEU . 1.5 mp -123.16 138.08 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 115.193 -0.912 . . . . 13.9 110.503 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 94.2 t80 -139.31 127.07 21.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.274 -0.876 . . . . 6.86 108.921 177.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.02 39.17 18.33 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.121 -0.49 . . . . 11.15 111.424 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . 0.743 ' HA2' HD12 ' A' ' 71' ' ' LEU . . . 82.02 -0.0 89.06 Favored Glycine 0 CA--C 1.532 1.107 0 N-CA-C 114.9 0.72 . . . . 13.93 114.9 176.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 35.4 mtmt -112.2 139.26 47.88 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 118.769 1.284 . . . . 23.92 111.748 -178.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . 0.55 ' HB2' ' O ' ' A' ' 71' ' ' LEU . 27.7 tt0 -79.35 128.96 33.99 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 107.645 -1.243 . . . . 23.23 107.645 178.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 46.9 mt -86.95 136.52 32.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.874 0.369 . . . . 9.11 111.53 -178.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -91.17 149.91 21.59 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.207 0.527 . . . . 33.44 112.003 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -68.83 -20.06 64.29 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.542 0.941 . . . . 28.37 113.542 -177.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.97 3.42 70.34 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 121.166 -0.54 . . . . 15.0 113.11 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 68.6 mmt-85 -110.05 165.91 11.36 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 117.644 0.722 . . . . 25.5 111.292 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 71.2 p -107.52 167.37 9.99 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-O 121.553 0.692 . . . . 11.95 111.965 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 91.3 mt -59.99 -42.94 95.31 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 114.843 -1.071 . . . . 10.17 110.951 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 84.1 p -61.86 -30.34 70.79 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 119.685 -0.806 . . . . 13.59 111.91 -178.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -62.07 -28.96 69.98 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.652 -0.419 . . . . 11.7 110.495 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -99.92 13.81 32.6 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.274 -0.421 . . . . 12.95 111.646 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 50.0 40.08 20.4 Favored 'General case' 0 C--O 1.231 0.11 0 N-CA-C 112.034 0.383 . . . . 25.45 112.034 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 91.0 mt -81.11 121.49 34.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 107.36 -1.348 . . . . 14.6 107.36 178.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -107.45 169.15 8.76 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.309 0.576 . . . . 33.23 112.069 -177.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 52.6 pttt -51.13 141.21 14.73 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.103 -0.953 . . . . 25.97 111.639 -178.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 66.77 23.31 10.13 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 114.752 -1.113 . . . . 32.61 112.941 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' SER . . . . . . . . . . . . . 37.0 m -76.83 148.67 36.42 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.009 -1.108 . . . . 10.56 108.009 176.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 93.9 m -112.79 124.08 51.78 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 109.54 -0.541 . . . . 5.33 109.54 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.41 ' N ' HD12 ' B' ' 67' ' ' LEU . 4.0 mp -105.19 157.35 17.34 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 107.642 -1.244 . . . . 11.66 107.642 177.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . 1.657 ' CE1' ' HA ' ' A' ' 9' ' ' THR . 77.5 m80 -112.18 134.09 53.93 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.232 -0.655 . . . . 16.3 109.232 179.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 26.7 tp -106.21 132.72 51.93 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.895 -0.78 . . . . 9.96 108.895 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 1.025 HG11 HG21 ' A' ' 70' ' ' VAL . 2.6 t -120.74 144.85 28.34 Favored 'Isoleucine or valine' 0 C--N 1.344 0.334 0 N-CA-C 107.561 -1.274 . . . . 9.76 107.561 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 41.3 mt -109.88 140.03 44.29 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.33 -0.85 . . . . 19.57 110.615 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 36.6 ttt180 . . . . . 0 N--CA 1.465 0.285 0 CA-C-N 115.69 -0.686 . . . . 35.08 110.0 -179.918 . . . . . . . . 0 0 . 1 stop_ save_